Serum miR-142-3p is associated with early relapse in operable lung adenocarcinoma patients.
Kaduthanam S, Gade S, Meister M, Brase JC, Johannes M, Dienemann H, Warth A, Schnabel PA, Herth FJ, Sültmann H, Muley T, Kuner R.
Kaduthanam S, et al. Among authors: dienemann h.
Lung Cancer. 2013 May;80(2):223-7. doi: 10.1016/j.lungcan.2013.01.013. Epub 2013 Feb 11.
Lung Cancer. 2013.
PMID: 23410826